Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
From - Diagnostic Testing & Emerging Technologies
Child–parent hypercholesterolemia (FH) screening is a practical and effective way of conducting population-based screening to identify the…
From - Diagnostic Testing & Emerging Technologies
Epigenetic changes, measured by DNA methylation, may be a predictor of biological age, according to a study published in…
From - Diagnostic Testing & Emerging Technologies
In a show of bipartisanship and further support of precision medicine and health care innovation—including genomics and other diagnostic innovations…